~~<i id='8E490E48D3'><strike id='8E490E48D3'><tt id='8E490E48D3'><pre id='8E490E48D3'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：comprehensive 2025-10-01 12:12:04 - browse：2

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Men with early prostate cancer can safely opt out of treatment

knowledge

hotspot

focus

knowledge

focus

leisure time

CourtesyRyanPickeringPROVIDENCE–InlateAugust,Dr.JamesE.FanalewastrudgingthroughtheFalmouthRoadRace—w

WSS

PrEP can help anyone prevent HIV. Why do so few people take it?

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

What Henrietta Lacks's story taught me about my role as a doctor

Inside the culture of fear in the White House science office of Eric Lander

Severe heat forecast: Where scorching temperatures will persist over the next week

Burning questions about Delta and the next phase of the Covid pandemic

focus

hotspot

knowledge

Supreme Court strikes down use of affirmative action

What health policies could hitch a ride on a spending bill?

Jerome Adams on the need for new antivirals for Covid

Medicare’s new pay boost for primary care is angering specialists

The cancer drug shortage isn’t new — and neither are the solutions

Novartis develops a rapidly manufactured CAR

After affirmative action ruling, medical educators look to 'holistic review'

Severe heat forecast: Where scorching temperatures will persist over the next week

Anesthesiologist group: stop taking Ozempic before surgery

Men with early prostate cancer can safely opt out of treatment

hotspot

What health policies could hitch a ride on a spending bill?

How a key Senate committee is planning to regulate PBMs

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

NIH chief: government has fallen behind pharma on clinical trials

UnitedHealth sued over use of algorithm in Medicare Advantage plans

focus

knowledge

focus

leisure time